Walmart Offers Free GLP-1 Drugs and Meds in Benefit Overhaul

Walmart is expanding its employee healthcare benefits by offering more than 250 medications at zero cost, including specific treatments like insulin, inhalers, and GLP-1 drugs for type 2 diabetes, while also implementing a minor increase to starting health insurance premiums. The broader benefits package rolls out during the annual enrollment season concluding on November 6 for its domestic workforce.

"We’re adding even more ways to help you and your family live better through comprehensive and affordable healthcare and benefits," said Donna Morris, Chief People Officer, in an internal memo regarding the updates.

Premium Adjustments Across the Workforce

As the largest U.S. private employer, Walmart supports approximately 1.6 million domestic workers across its retail and supply chain operations. Alongside the introduction of free medications, the company is adjusting its contribution structures by raising starting health insurance premiums by $1.50 per biweekly pay period to reach $39.80.

This structural shift balances out-of-pocket costs for chronic disease maintenance against slightly higher baseline deductions. By absorbing the cost of frequently prescribed maintenance medications, the retailer aims to reduce overall chronic care expenses for lower-income hourly workers who might otherwise ration essential therapies.

Specialized Care and Family Leave Additions

Beyond daily prescriptions, the expanded healthcare package introduces coverage for specialist treatments at nationally recognized medical institutions, including the Mayo Clinic and Cleveland Clinic. These centers of excellence provide targeted care for complex and serious conditions such as cancer, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS).

Additionally, Fox Business reported that Walmart is establishing up to 12 weeks of dedicated paid leave for employees whose newborns require care in a neonatal intensive care unit. This leave policy is scheduled to take effect nationwide on November 17.

Market Valuation and Financial Context

In the public equity markets, Walmart Inc. (NYSE: WMT) shares closed at $118.81, rising 0.80% or $0.94 from its previous close of $117.87, according to Finnhub market data.

The expansion of corporate healthcare benefits highlights an ongoing trend among large employers attempting to retain retail and logistics personnel through enhanced medical perks. Providing zero-cost access to high-demand pharmaceutical products like GLP-1 receptor agonists directly addresses one of the fastest-growing drivers of employer-sponsored health plan expenditures.